Real‐world data from a single Greek centre on the use of secukinumab in plaque psoriasis: effectiveness, safety, drug survival, and identification of patients that sustain optimal response

Background Few studies have investigated the long‐term outcomes of secukinumab in real‐life psoriasis treatment where diverse patient profiles require a personalized approach. Objectives To determine long‐term performance of secukinumab in moderate‐to‐severe plaque psoriasis, and identify potential...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2020-06, Vol.34 (6), p.1240-1247
Hauptverfasser:	Rompoti, N., Sidiropoulou, P., Panagakis, P., Stratigos, A., Papoutsaki, M., Stefanaki, E., Vavouli, C., Politou, M., Befon, A., Kostakis, P., Rigopoulos, D., Nicolaidou, E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal, Humanized Female Greece Humans Male Middle Aged Pharmaceutical Preparations Psoriasis - drug therapy Retrospective Studies Severity of Illness Index Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!